Continued Discoveries About Lifesaving Vaccines
More than two centuries since the invention of the first vaccine, a great deal is still being uncovered about lifesaving sera.
Making Strides in Patient Safety
Efforts to optimize patient care continue, with a push toward tackling a myriad of problems, from antimicrobial resistance to autism spectrum disorder.
Discoveries in Treatment and Illness Prevention
Scientists are making discoveries that are leading to prevention and better treatments, and clinicians are discovering new approaches to improving delivery of health services so clients receive a continuum of preventive and curative services.
The Exciting Future of Medicine
Advances are leading to promising treatments and cures for diseases that have plagued society for decades, as well as new methods that promise to substantially improve quality of care.
Despite Vaccine Benefits, Challenges Persist
Scientists continue to work toward a universal flu vaccine and alternate vaccine delivery systems in hopes of increasing vaccine rates.
Patient Safety Is a Collective Responsibility
Patient safety is an endemic concern — one that must be addressed by many stakeholders, including government agencies, manufacturers, healthcare providers and others, all working collectively to safely care for patients.
Leveraging the Benefits of Biologic Medicines
With the growing demand for biologics, biosimilars promise additional treatment options, but their introduction is not without challenges.
Advancing Healthcare: From Testing to Treatment
On average, only 25 new experimental drugs were approved by the FDA’s Center for Drug Evaluation and Research (CDER) every year during the past decade. Taking more than 10 years to go from testing to treatment, the healing properties of these drugs help countless numbers of patients, sometimes providing life-changing and lifesaving results.
Addressing Declining Vaccination Rates
A “vaccination gap” has resulted in fewer children receiving the recommended immunizations, and diseases that were once considered all but eliminated are reemerging.
Safe Medicine: A Shared Responsibility
FFF Enterprises takes a “safety first” approach when it comes to business best practices for distributing fragile biologics and transport-sensitive vaccines.